Prehabilitation in Geriatric Patients With Colorectal Neoplasia
NCT ID: NCT05851235
Last Updated: 2023-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
25 participants
INTERVENTIONAL
2023-03-22
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will follow an intensive prehabilitation course before surgery:
* Colon cancer patients will do 4 weeks of prehabilitation before surgery.
* Rectal cancer patients will do 12 weeks of prehabilitation after neoadjuvant therapy and before surgery.
The prehabilitation course is structured around the following aspects:
* Frailty assessment and identification of optimisation fields
* Optimisation of modifiable factors (anaemia, polypharmacotherapy, smoking, alcoholism, diabetes)
* Assessment by an integrative medicine specialist
* Nutritional pre-qualification
* Cardiovascular, respiratory, motor prehabilitation
* Emotional and psychological prehabilitation
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prehabilitation in Colorectal Cancer
NCT03096951
Prehabilitation in Rectal Cancer: During Neoadjuvant Therapy vs Preoperative
NCT05286086
Prehabilitation in Frail Colon Cancer
NCT03097224
Effect of Multimodal Prehabilitation After Colorectal Cancer Surgery
NCT05854394
Telerehabilitation in Cancer Patients: Optimization of Prehabilitation and Rehabilitation Following Colorectal Resection
NCT06593678
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Colorectal cancer patients
Patients with colon or rectal cancer awaiting surgery
Prehabilitation course
During prehabilitation course, patients will follow a nutritional programme, a cardiovascular and motor programme and a psychological programme.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prehabilitation course
During prehabilitation course, patients will follow a nutritional programme, a cardiovascular and motor programme and a psychological programme.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male/female participants who are at least 70 years of age on the day of signing informed consent.
3. Patients with confirmed diagnosis of colorectal cancer awaiting major surgery.
Exclusion Criteria
2. Severe cognitive impairment (MMSE\<20\*)
3. Severe dependency (ADL\<3)
4. Stage IV colorectal neoplasia
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Oncologico Romagnolo (IOR)
UNKNOWN
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isacco Montroni, MD
Role: STUDY_CHAIR
AUSL della Romagna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AUSL della Romagna
Ravenna, RA, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRST153.08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.